41 Results

for author "Roch Houot"

Type a term to search within all articles in this journal: e.g., stem cell
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-01-23
e.g., 2017-01-23
Format Results
  • Ibrutinib in Association with R-DHAP/Ox for Patients with Relapsed/Refractory B-Cell Lymphoma: Preliminary Results of the Biblos Phase Ib Lysa Study
    Christophe Bonnet, Thierry Lamy, Christophe Fruchart, Steven Le Gouill, Katharina Gunzer, Thomas Gastinne, Fabrice Jardin, Lionel Karlin, Roch Houot, Jehan Dupuis, Hervé Tilly, Gilles A. Salles
    ..., Steven Le Gouill , MD PhD * , 4 , Katharina Gunzer , MD * , 5 , Thomas Gastinne , MD * , 6 , Fabrice Jardin , MD PhD * , 7 , Lionel Karlin , MD * , 8 , Roch Houot , MD PhD * , 9 , Jehan Dupuis , MD * , 10 ~~~
  • Distinct patterns of B-cell receptor signaling in non-Hodgkins' lymphomas identified by single cell profiling
    June H. Myklebust, Joshua Brody, Holbrook E. Kohrt, Arne Kolstad, Debra K. Czerwinski, Sébastien Wälchli, Michael R. Green, Gunhild Trøen, Knut Liestøl, Klaus Beiske, Roch Houot, Jan Delabie, Ash A. Alizadeh, Jonathan M. Irish, Ronald Levy
    ..., Michael R. Green 1 , Gunhild Trøen 4 , Knut Liestøl 5 , Klaus Beiske 4 , Roch Houot 6 , Jan Delabie 7 , Ash A. Alizadeh 1 , Jonathan M. Irish 1 , and Ronald Levy 1 , * 1 Department of Medicine ~~~
  • Efficacy of the Ribvd Regimen in High Risk Mantle Cell Lymphoma Patients As Defined By the Mipic Prognostic Score: Identification of KI67, LDH and Performance Status As Most Important Prognostic Factors (PF). a French Lysa Group Study
    Remy Gressin, Anne Moreau, Nicolas Daguindau, Adrien Tempescul, Sylvain Carras, Jean-Michel Pignon, Guillaume Cartron, Roch Houot, Caroline Dartigeas, Anne Schmitt, Krimo Bouabdallah, Jehan Dupuis, Christiane Mounier, Lionel Karlin, Fabrice Jardin, Luc Mathieu Fornecker, Selim Corm, Joel Fleury, Barbara Burroni, Loic Ysebaert, Steven Le Gouill
    ...Moreau , MD * , 3 , Nicolas Daguindau , MD * , 4 , Adrien Tempescul , MD * , 5 , Sylvain Carras , MD * , 6 , Jean-Michel Pignon , MD * , 7 , Guillaume Cartron , MD PhD * , 8 , Roch Houot , MD PhD * , 9 , 10 ~~~
  • T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
    Imane Azzaoui, Fabrice Uhel, Delphine Rossille, Celine Pangault, Joelle Dulong, Jerome Le Priol, Thierry Lamy, Roch Houot, Steven Le Gouill, Guillaume Cartron, Pascal Godmer, Krimo Bouabdallah, Noel Milpied, Gandhi Damaj, Karin Tarte, Thierry Fest, Mikael Roussel
    ...Imane S LeGouill Houot, R Rossille Thierry D Rossille J LePriol Guillaume Cartron, G N Milpied Steven Le Gouill Noel Bouabdallah Dulong, J R Houot Krimo Bouabdallah Lamy, T Gouill Pascal P Godmer Uhel, Fabrice Thierry, Fest Le Gouill, S Guillaume Cartron Milpied Noel J Dulong Fabrice, Uhel Lamy Thierry ~~~
  • The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database?
    Carole Soussain, Caroline Houillier, Herve Ghesquieres, Pierre Soubeyran, Olivier Chinot, Luc Taillandier, Roch Houot, Guido Ahle, Emmanuel Gyan, Cécile Chabrot, Marie-Pierre Moles, Sylvain Choquet, Philippe Agape, Vincent Delwail, Fabrice Jardin, Annie Brion, Gandhi Damaj, Olivier Casanovas, Luc Mathieu Fornecker, Michel Fabbro, Valerie Touitou, Nathalie Cassoux, Remy Gressin, Adrian Tempescul, Arnaud Jaccard, Pascal Bourquard, Franck Morschhauser, Khê Hoang-Xuan
    ..., Olivier Chinot , MD PhD * , 5 , Luc Taillandier , MD PhD * , 6 , Roch Houot , MD PhD * , 7 , 8 , Guido Ahle , MD * , 9 , Emmanuel Gyan , MD PhD 10 , Cécile Chabrot , MD * , 11 , Marie-Pierre Moles , MD * , 12 ~~~
  • A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma
    Franck Morschhauser, Guillaume Cartron, Gilles A. Salles, Fontanet Bijou, Christophe Fruchart, Krimo Bouabdallah, Pierre Feugier, Steven Le Gouill, Hervé Tilly, Cecile moluçon-Chabrot, Marie Maerevoet, Rene-Olivier Casasnovas, Eric W Van Den Neste, Pierre Zachee, Koen Van Eygen, Achiel Van Hoof, Christophe Bonnet, Corinne Haioun, Marc Andre, Luc Xerri, Roch Houot
    ...Christophe, Bonnet Andre, M G.A. Salles R Houot Van Eygen Van Hoof, Achiel Bonnet, Christophe GA Salles Cecile moluçonChabrot Gilles A Salles Le Gouill, S Bonnet Christophe Bouabdallah, K Van ReneOlivier Casasnovas Hoof Haioun, C Salles, GA Casasnovas Morschhauser, F Fruchart, C Roch Houot Houot Roch ~~~
  • Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network
    Sylvain Choquet, Caroline Houillier, Fontanet Bijou, Roch Houot, Eileen Boyle, Remy Gressin, Emmanuelle Nicolas-Virelizier, Maryline Barrie, Cecile Molucon-Chabrot, Marie Blonski, Abderrazak El Yamani, Marie-Laure LeLez, Aline Clavert, Solène Coisy, Marjan Ertault de la Bretonnière, Valérie Touitou, Nathalie Cassoux, Sami Boussetta, Florence Broussais, Benedicte Gelas-Dore, Noélie Barzic, Herve Ghesquieres, Khê Hoang-Xuan, Carole Soussain
    ...* , 2 , Fontanet Bijou , MD 3 , Roch Houot , MD PhD * , 4 , Eileen Boyle , MD * , 5 , Remy Gressin , MD 6 , Emmanuelle Nicolas-Virelizier , MD * , 7 , Maryline Barrie , MD * , 8 , Cecile Molucon-Chabrot , MD ~~~
  • Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers
    Sylvain Chantepie, Emmanuelle Tchernonog, Frederic Peyrade, Marie-Virginie Larcher, Momar Diouf, Luc Mathieu Fornecker, Roch Houot, Thomas Gastinne, Carole Soussain, Sandra Malak, Olivier Tournilhac, Caroline Delette, Ahmad Ibrahim, Anne-Claire Gac, Jean-Pierre Vilque, Mohamed Amine Bekadja, Rene-Olivier Casasnovas, Remy Gressin, Arnaud Jaccard, Benjamin Carpentier, Reda Garidi, Bachra Choufi, Stéphanie Guidez, Adrian Tempescul, Adrien Chauchet, Emmanuel Gyan, Ibrahim Yakoub-Agha, Krimo Bouabdallah, Eric Durot, Gandhi Damaj
    ..., Marie-Virginie Larcher , MD * , 4 , Momar Diouf , MD * , 5 , Luc Mathieu Fornecker , MD PhD * , 6 , Roch Houot , MD PhD * , 7 , Thomas Gastinne , MD * , 8 , Carole Soussain , MD PhD 9 , Sandra Malak , MD * , 10 ~~~
  • Inhibition of Hedgehog Signaling for the Treatment of Lymphoma and CLL: A Phase II Study from the Lysa
    Roch Houot, Carole Soussain, Hervé Tilly, Corinne Haioun, Catherine Thieblemont, Olivier Casasnovas, Krimo Bouabdallah, Franck Morschhauser, Steven Le Gouill, Gilles A. Salles, Tony Marchand, Céline Pangault, Camille Laurent, Thierry Lamy
    ...Inhibition of Hedgehog Signaling for the Treatment of Lymphoma and CLL: A Phase II Study from the Lysa [] Olivier Gilles Salles Haioun, Corinne Steven, Le Gouill GillesA Salles Lamy Casasnovas, O Pangault Céline Roch Houot Le Gouill Steven Le Catherine Thieblemont Salles, G.A Céline Pangault Lamy ~~~
  • Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
    Charles Herbaux, Jordan Gauthier, Pauline Brice, Luc Fornecker, Krimo Bouabdallah, Guillaume Manson, Hervé Ghesquières, Anne Thiebaut-Bertrand, Hélène Demarquette, Eileen Boyle, Loic Ysebaert, Roch Houot, Ibrahim Yakoub-Agha, Franck Morschhauser
    ...Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC [] Thiebaut-Bertrand Anne Eileen Yakoub-Agha Ibrahim Hélène Demarquette, Hélène Gauthier Boyle, E Fornecker Luc Roch Houot ~~~